{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:55:59Z","timestamp":1777496159013,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008665","name":"Osaka Medical Research Foundation for Intractable Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24322"],"award-info":[{"award-number":["23K24322"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0210107h0002"],"award-info":[{"award-number":["JP23fk0210107h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["1646"],"award-info":[{"award-number":["1646"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.labinv.2025.104226","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:49:12Z","timestamp":1754495352000},"page":"104226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Significance of Poly (ADP-Ribose) Polymerase 1 Binding Protein Expression and CD8+ Tumor-Infiltrating Lymphocytes in Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9413-8600","authenticated-orcid":false,"given":"Masako","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misako","family":"Sato-Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Truong Huu","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9242-1245","authenticated-orcid":false,"given":"Sawako","family":"Uchida-Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-4864","authenticated-orcid":false,"given":"Akihiro","family":"Tamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-1052","authenticated-orcid":false,"given":"Tsutomu","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2358-7452","authenticated-orcid":false,"given":"Kenichi","family":"Kohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-6973","authenticated-orcid":false,"given":"Takeaki","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6392-8311","authenticated-orcid":false,"given":"Norifumi","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.labinv.2025.104226_bib1","first-page":"209","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.labinv.2025.104226_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","article-title":"Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis","volume":"261","author":"Tabrizian","year":"2015","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.labinv.2025.104226_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/cancers16030666","article-title":"Management of hepatocellular carcinoma in 2024: the multidisciplinary paradigm in an evolving treatment landscape","volume":"16","author":"Kinsey","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.labinv.2025.104226_bib4","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3390\/cancers15082311","article-title":"Role of \u03b2-catenin activation in the tumor immune microenvironment and immunotherapy of hepatocellular carcinoma","volume":"15","author":"Morita","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.labinv.2025.104226_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhep.2005.12.027","article-title":"Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation","volume":"45","author":"Unitt","year":"2006","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.labinv.2025.104226_bib6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ajpath.2022.02.004","article-title":"The functional roles of immune cells in primary liver cancer","volume":"192","author":"Pham","year":"2022","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.labinv.2025.104226_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (tils) in breast cancer: recommendations by an international tils working group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104226_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/gcc.20828","article-title":"C12orf48, termed parp-1 binding protein, enhances poly(adp-ribose) polymerase-1 (parp-1) activity and protects pancreatic cancer cells from DNA damage","volume":"50","author":"Piao","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.labinv.2025.104226_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","article-title":"Expansion of cancer risk profile for brca1 and brca2 pathogenic variants","volume":"8","author":"Momozawa","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104226_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-020-01227-0","article-title":"Parp inhibitor resistance: the underlying mechanisms and clinical implications","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.labinv.2025.104226_bib11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00280-015-2852-2","article-title":"Phase ii study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma","volume":"76","author":"Gabrielson","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"issue":"15","key":"10.1016\/j.labinv.2025.104226_bib12","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.3390\/cancers14153806","article-title":"Poly(adp-ribose) polymerase inhibition as a promising approach for hepatocellular carcinoma therapy","volume":"14","author":"Paturel","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"42","key":"10.1016\/j.labinv.2025.104226_bib13","doi-asserted-by":"crossref","first-page":"26356","DOI":"10.1073\/pnas.2002917117","article-title":"Rational combination therapy for hepatocellular carcinoma with parp1 and DNA-pk inhibitors","volume":"117","author":"Wang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.labinv.2025.104226_bib14","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s10620-019-05608-4","article-title":"Overexpression of PARPBP correlates with tumor progression and poor prognosis in hepatocellular carcinoma","volume":"64","author":"Yu","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"26","key":"10.1016\/j.labinv.2025.104226_bib15","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"Pd-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.labinv.2025.104226_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40364-020-00202-7","article-title":"Role of DNA repair defects in predicting immunotherapy response","volume":"8","author":"Zhang","year":"2020","journal-title":"Biomark Res"},{"issue":"6","key":"10.1016\/j.labinv.2025.104226_bib17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"Parp inhibitor efficacy depends on cd8+ t-cell recruitment via intratumoral sting pathway activation in brca-deficient models of triple-negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.labinv.2025.104226_bib18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/hepr.13411","article-title":"Clinical practice guidelines for hepatocellular carcinoma: The japan society of hepatology 2017 (4th jsh-hcc guidelines) 2019 update","volume":"49","author":"Kokudo","year":"2019","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.labinv.2025.104226_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"10.1016\/j.labinv.2025.104226_bib20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/archsurg.134.9.984","article-title":"No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: Is there a way? A prospective analysis of our approach","volume":"134","author":"Torzilli","year":"1999","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.labinv.2025.104226_bib21","first-page":"385","article-title":"Establishment and some biological characteristics of human hepatoma cell lines","volume":"66","author":"Dor","year":"1975","journal-title":"Gan"},{"issue":"16","key":"10.1016\/j.labinv.2025.104226_bib22","first-page":"3831","article-title":"Increased expression of the insulin-like growth factor i (igf-i) receptor gene in hepatocellular carcinoma cell lines: Implications of igf-i receptor gene activation by hepatitis b virus x gene product","volume":"56","author":"Kim","year":"1996","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.labinv.2025.104226_bib23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/1615-9861(200110)1:10<1249::AID-PROT1249>3.0.CO;2-1","article-title":"Hepatocellular carcinoma: From bedside to proteomics","volume":"1","author":"Seow","year":"2001","journal-title":"Proteomics"},{"issue":"7","key":"10.1016\/j.labinv.2025.104226_bib24","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ajpath.2024.03.004","article-title":"Poorly differentiated hepatocellular carcinoma cells avoid apoptosis by interacting with t cells via cd40-cd40 ligand linkage","volume":"194","author":"Vinh","year":"2024","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.labinv.2025.104226_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'ezr' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.labinv.2025.104226_bib26","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/nar\/gkw024","article-title":"The pcna-associated protein pari negatively regulates homologous recombination via the inhibition of DNA repair synthesis","volume":"44","author":"Burkovics","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.labinv.2025.104226_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molcel.2011.11.010","article-title":"Inhibition of homologous recombination by the pcna-interacting protein pari","volume":"45","author":"Moldovan","year":"2012","journal-title":"Mol Cell"},{"issue":"5","key":"10.1016\/j.labinv.2025.104226_bib28","first-page":"574","article-title":"Poly (adp-ribose) polymerase-1 binding protein facilitates lung adenocarcinoma cell proliferation and correlates with poor prognosis","volume":"49","author":"Xu","year":"2019","journal-title":"Ann Clin Lab Sci"},{"issue":"8","key":"10.1016\/j.labinv.2025.104226_bib29","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1158\/0008-5472.CAN-12-3313","article-title":"Pari overexpression promotes genomic instability and pancreatic tumorigenesis","volume":"73","author":"O'Connor","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2025.104226_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920974212","article-title":"PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer","volume":"12","author":"Chen","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"27","key":"10.1016\/j.labinv.2025.104226_bib31","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1038\/s41388-019-0810-x","article-title":"Pari (PARPBP) suppresses replication stress-induced myeloid differentiation in leukemia cells","volume":"38","author":"Nicolae","year":"2019","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.labinv.2025.104226_bib32","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajpath.2013.10.028","article-title":"The changing landscape of hepatocellular carcinoma: Etiology, genetics, and therapy","volume":"184","author":"Knudsen","year":"2014","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104226_bib33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000516899","article-title":"Immunological microenvironment predicts the survival of the patients with hepatocellular carcinoma treated with anti-pd-1 antibody","volume":"10","author":"Morita","year":"2021","journal-title":"Liver Cancer"},{"issue":"4","key":"10.1016\/j.labinv.2025.104226_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154515","article-title":"\u03b2-catenin signaling in hepatocellular carcinoma","volume":"132","author":"Xu","year":"2022","journal-title":"J Clin Invest"},{"issue":"7559","key":"10.1016\/j.labinv.2025.104226_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.labinv.2025.104226_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/PAS.0b013e31824e9b7c","article-title":"Role of foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma","volume":"36","author":"Mathai","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104226_bib37","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of cd39 and cd103 identifies tumor-reactive cd8 t cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.labinv.2025.104226_bib38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1158\/2767-9764.CRC-22-0265","article-title":"Reprogramming of tumor-reactive tumor-infiltrating lymphocytes to human-induced pluripotent stem cells","volume":"3","author":"Islam","year":"2023","journal-title":"Cancer Res Commun"},{"issue":"3","key":"10.1016\/j.labinv.2025.104226_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/ol.2022.13213","article-title":"Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma","volume":"23","author":"Tomiyama","year":"2022","journal-title":"Oncol Lett"},{"issue":"7","key":"10.1016\/j.labinv.2025.104226_bib40","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.hpb.2020.11.002","article-title":"The cd68+ macrophages to cd8+ t-cell ratio is associated with clinical outcomes in hepatitis b virus (hbv)-related hepatocellular carcinoma","volume":"23","author":"Xin","year":"2021","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.labinv.2025.104226_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.816642","article-title":"Targeting parp1 to enhance anticancer checkpoint immunotherapy response: Rationale and clinical implications","volume":"13","author":"Wanderley","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104226_bib42","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","article-title":"World-wide relative contribution of hepatitis b and c viruses in hepatocellular carcinoma","volume":"62","author":"de Martel","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.labinv.2025.104226_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/biom6010002","article-title":"Activation of the DNA damage response by rna viruses","volume":"6","author":"Ryan","year":"2016","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.labinv.2025.104226_bib44","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3390\/cancers13112625","article-title":"Virus-driven carcinogenesis","volume":"13","author":"Hatano","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.labinv.2025.104226_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2020.105325","article-title":"Data of cytotoxicity, p53 and akt downstream proteins and physiological indexes in hepatocellular carcinoma cells or hepg2-bearing nude mouse model administered by \u03b1-humulene","volume":"29","author":"Chen","year":"2020","journal-title":"Data Brief"},{"issue":"23","key":"10.1016\/j.labinv.2025.104226_bib46","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1111\/jcmm.15962","article-title":"Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting bcl-2 gene expression through an ra-rar signalling pathway","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10.1016\/j.labinv.2025.104226_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000422","article-title":"Alpha-fetoprotein: past, present, and future","volume":"8","author":"Yeo","year":"2024","journal-title":"Hepatol Commun"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:03:12Z","timestamp":1777388592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683725001369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0023683725001369"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104226","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Significance of Poly (ADP-Ribose) Polymerase 1 Binding Protein Expression and CD8+ Tumor-Infiltrating Lymphocytes in Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"104226"}}